Financhill
Sell
22

BEAT Quote, Financials, Valuation and Earnings

Last price:
$2.27
Seasonality move :
-33.73%
Day range:
$2.17 - $2.40
52-week range:
$1.35 - $3.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
12.44x
Volume:
205.2K
Avg. volume:
237.6K
1-year change:
-6.67%
Market cap:
$59.7M
Revenue:
--
EPS (TTM):
-$0.68

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
BEAT
HeartBeam
-- -- -- -- $5.00
DRIO
DarioHealth
$7.4M -$0.16 104.95% -60.98% $3.50
FOXO
FOXO Technologies
-- -- -- -- --
OTRK
Ontrak
$3.1M -- -13% -- --
SPOK
Spok Holdings
$35.5M $0.24 4.56% 18.18% --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
BEAT
HeartBeam
$2.24 $5.00 $59.7M -- $0.00 0% --
DRIO
DarioHealth
$0.89 $3.50 $30.5M -- $0.00 0% 1.39x
FOXO
FOXO Technologies
$0.31 -- $5.4M -- $0.00 0% 2.30x
OTRK
Ontrak
$1.84 -- $7.8M -- $0.00 0% 0.63x
SPOK
Spok Holdings
$16.03 -- $325M 21.96x $0.31 7.8% 2.38x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
BEAT
HeartBeam
-- 3.225 -- --
DRIO
DarioHealth
33.03% -0.172 82.25% 1.27x
FOXO
FOXO Technologies
224.55% 17.369 1241.69% 0.06x
OTRK
Ontrak
40.88% 4.339 95.85% 0.98x
SPOK
Spok Holdings
-- 0.549 -- 1.08x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
BEAT
HeartBeam
-- -$5.1M -- -- -- -$3.4M
DRIO
DarioHealth
$3.9M -$12M -49.97% -71.65% -162.06% -$7.4M
FOXO
FOXO Technologies
$655K -$1.1M -- -- -83.28% $576K
OTRK
Ontrak
$1.6M -$5.1M -149.3% -231.34% -198.72% -$1.4M
SPOK
Spok Holdings
$27.7M $5.3M 9.13% 9.13% 15.31% $10.3M

HeartBeam vs. Competitors

  • Which has Higher Returns BEAT or DRIO?

    DarioHealth has a net margin of -- compared to HeartBeam's net margin of -166.11%. HeartBeam's return on equity of -- beat DarioHealth's return on equity of -71.65%.

    Company Gross Margin Earnings Per Share Invested Capital
    BEAT
    HeartBeam
    -- -$0.19 --
    DRIO
    DarioHealth
    52.23% -$0.25 $87.4M
  • What do Analysts Say About BEAT or DRIO?

    HeartBeam has a consensus price target of $5.00, signalling upside risk potential of 123.21%. On the other hand DarioHealth has an analysts' consensus of $3.50 which suggests that it could grow by 291.11%. Given that DarioHealth has higher upside potential than HeartBeam, analysts believe DarioHealth is more attractive than HeartBeam.

    Company Buy Ratings Hold Ratings Sell Ratings
    BEAT
    HeartBeam
    1 1 0
    DRIO
    DarioHealth
    3 0 0
  • Is BEAT or DRIO More Risky?

    HeartBeam has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth has a beta of 1.395, suggesting its more volatile than the S&P 500 by 39.491%.

  • Which is a Better Dividend Stock BEAT or DRIO?

    HeartBeam has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HeartBeam pays -- of its earnings as a dividend. DarioHealth pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BEAT or DRIO?

    HeartBeam quarterly revenues are --, which are smaller than DarioHealth quarterly revenues of $7.4M. HeartBeam's net income of -$5M is higher than DarioHealth's net income of -$12.3M. Notably, HeartBeam's price-to-earnings ratio is -- while DarioHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HeartBeam is -- versus 1.39x for DarioHealth. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BEAT
    HeartBeam
    -- -- -- -$5M
    DRIO
    DarioHealth
    1.39x -- $7.4M -$12.3M
  • Which has Higher Returns BEAT or FOXO?

    FOXO Technologies has a net margin of -- compared to HeartBeam's net margin of -162.71%. HeartBeam's return on equity of -- beat FOXO Technologies's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    BEAT
    HeartBeam
    -- -$0.19 --
    FOXO
    FOXO Technologies
    54.77% -$0.15 $14M
  • What do Analysts Say About BEAT or FOXO?

    HeartBeam has a consensus price target of $5.00, signalling upside risk potential of 123.21%. On the other hand FOXO Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that HeartBeam has higher upside potential than FOXO Technologies, analysts believe HeartBeam is more attractive than FOXO Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    BEAT
    HeartBeam
    1 1 0
    FOXO
    FOXO Technologies
    0 0 0
  • Is BEAT or FOXO More Risky?

    HeartBeam has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison FOXO Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock BEAT or FOXO?

    HeartBeam has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FOXO Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HeartBeam pays -- of its earnings as a dividend. FOXO Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BEAT or FOXO?

    HeartBeam quarterly revenues are --, which are smaller than FOXO Technologies quarterly revenues of $1.2M. HeartBeam's net income of -$5M is lower than FOXO Technologies's net income of -$1.9M. Notably, HeartBeam's price-to-earnings ratio is -- while FOXO Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HeartBeam is -- versus 2.30x for FOXO Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BEAT
    HeartBeam
    -- -- -- -$5M
    FOXO
    FOXO Technologies
    2.30x -- $1.2M -$1.9M
  • Which has Higher Returns BEAT or OTRK?

    Ontrak has a net margin of -- compared to HeartBeam's net margin of -217.21%. HeartBeam's return on equity of -- beat Ontrak's return on equity of -231.34%.

    Company Gross Margin Earnings Per Share Invested Capital
    BEAT
    HeartBeam
    -- -$0.19 --
    OTRK
    Ontrak
    62.05% -$1.77 $19.4M
  • What do Analysts Say About BEAT or OTRK?

    HeartBeam has a consensus price target of $5.00, signalling upside risk potential of 123.21%. On the other hand Ontrak has an analysts' consensus of -- which suggests that it could grow by 117.39%. Given that HeartBeam has higher upside potential than Ontrak, analysts believe HeartBeam is more attractive than Ontrak.

    Company Buy Ratings Hold Ratings Sell Ratings
    BEAT
    HeartBeam
    1 1 0
    OTRK
    Ontrak
    0 0 0
  • Is BEAT or OTRK More Risky?

    HeartBeam has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ontrak has a beta of 2.540, suggesting its more volatile than the S&P 500 by 154.002%.

  • Which is a Better Dividend Stock BEAT or OTRK?

    HeartBeam has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ontrak offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HeartBeam pays -- of its earnings as a dividend. Ontrak pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios BEAT or OTRK?

    HeartBeam quarterly revenues are --, which are smaller than Ontrak quarterly revenues of $2.6M. HeartBeam's net income of -$5M is higher than Ontrak's net income of -$5.6M. Notably, HeartBeam's price-to-earnings ratio is -- while Ontrak's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HeartBeam is -- versus 0.63x for Ontrak. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BEAT
    HeartBeam
    -- -- -- -$5M
    OTRK
    Ontrak
    0.63x -- $2.6M -$5.6M
  • Which has Higher Returns BEAT or SPOK?

    Spok Holdings has a net margin of -- compared to HeartBeam's net margin of 10.5%. HeartBeam's return on equity of -- beat Spok Holdings's return on equity of 9.13%.

    Company Gross Margin Earnings Per Share Invested Capital
    BEAT
    HeartBeam
    -- -$0.19 --
    SPOK
    Spok Holdings
    79.54% $0.18 $156.3M
  • What do Analysts Say About BEAT or SPOK?

    HeartBeam has a consensus price target of $5.00, signalling upside risk potential of 123.21%. On the other hand Spok Holdings has an analysts' consensus of -- which suggests that it could fall by -6.43%. Given that HeartBeam has higher upside potential than Spok Holdings, analysts believe HeartBeam is more attractive than Spok Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    BEAT
    HeartBeam
    1 1 0
    SPOK
    Spok Holdings
    0 0 0
  • Is BEAT or SPOK More Risky?

    HeartBeam has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings has a beta of 0.342, suggesting its less volatile than the S&P 500 by 65.754%.

  • Which is a Better Dividend Stock BEAT or SPOK?

    HeartBeam has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings offers a yield of 7.8% to investors and pays a quarterly dividend of $0.31 per share. HeartBeam pays -- of its earnings as a dividend. Spok Holdings pays out 163.68% of its earnings as a dividend.

  • Which has Better Financial Ratios BEAT or SPOK?

    HeartBeam quarterly revenues are --, which are smaller than Spok Holdings quarterly revenues of $34.9M. HeartBeam's net income of -$5M is lower than Spok Holdings's net income of $3.7M. Notably, HeartBeam's price-to-earnings ratio is -- while Spok Holdings's PE ratio is 21.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HeartBeam is -- versus 2.38x for Spok Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    BEAT
    HeartBeam
    -- -- -- -$5M
    SPOK
    Spok Holdings
    2.38x 21.96x $34.9M $3.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will American Tower Stock Recover?
Will American Tower Stock Recover?

The performance of the real estate investment trust, or REIT,…

Will Booking Holdings Stock Split?
Will Booking Holdings Stock Split?

Booking Holdings, the travel and technology company that owns brands…

Why Buy Domino’s Pizza Stock?
Why Buy Domino’s Pizza Stock?

When you think of growth stocks, you probably imagine technology…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 121x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
70
OKLO alert for Jan 6

Oklo [OKLO] is up 10.09% over the past day.

Sell
39
DOGZ alert for Jan 6

Dogness (International) [DOGZ] is up 3.39% over the past day.

Buy
66
DMRC alert for Jan 6

Digimarc [DMRC] is up 1.05% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock